r/PharmAla_MDMA

▲ 5 r/PharmAla_MDMA+1 crossposts

Genevieve Jurvetson (@gjurvetson) on X

“When Resilient submits its updated data to the FDA, I hope the FDA prioritizes the review. It is the only program with completed Phase 3 trials for PTSD and is positioned to begin treating patients immediately following approval.”

x.com
u/Firefly5647 — 2 days ago